About Us
We know it because we use it too!
GLP‑1 Prescription and Compliance Disclosure
​
At My Weight Loss Partner, we prioritize patient safety and regulatory compliance in all GLP‑1–based weight‑management programs. Our team operates strictly within federal and state laws governing prescription medications and telehealth practice.
​
Medical Oversight
All GLP‑1 treatments, including semaglutide and tirzepatide options, are available exclusively through prescriptions issued by licensed medical providers following appropriate clinical evaluations. We do not sell or distribute compounded medications unless such formulations are legally permissible and FDA supply shortages have been declared.
​
Legal and Ethical Standards
We follow all FDA, FTC, and Michigan Board of Pharmacy guidelines on advertising and drug safety. Our information is intended for educational purposes only and should not replace professional medical advice. We make no claims of guaranteed weight loss or permanent results.
​
Risk Transparency
GLP‑1 treatments may cause side effects such as nausea, vomiting, diarrhea, and other gastrointestinal symptoms. Medical eligibility is determined individually by a licensed provider.
​
Data Privacy
We protect all personal and health data in accordance with HIPAA regulations. We do not share medical information without patient consent.
Disclaimer
Results vary based on individual health factors. All GLP‑1 medications are available only by prescription. Consult with a licensed healthcare provider to determine if treatment is appropriate.
​
💡Patient Education Resources
Learn more about GLP‑1 therapy from trusted sources: